Thinking about whether Colgate-Palmolive stock is attractively priced? Let's break down what's really driving its value, so you can feel confident about your next move.

Recently, shares have seen a modest recovery of 2.1% over the past week and month, although they're still down 13.2% year to date and 11.7% over the last year.

Several analysts and market watchers have highlighted consumer staples resilience and shifting spending trends, especially as shoppers adjust to changing economic conditions. Colgate-Palmolive's strong global brand and defensive portfolio have kept it in the spotlight as investors search for stability amid market uncertainty.

On our valuation checks, Colgate-Palmolive scores 3 out of 6 for being undervalued. This means there is plenty to unpack in the numbers. Let’s walk through the main approaches to valuing this stock and, later on, explore a fresh angle that could give you the clearest view yet.

Colgate-Palmolive delivered -11.7% returns over the last year. See how this stacks up to the rest of the Household Products industry.

The Discounted Cash Flow (DCF) model estimates a company's intrinsic value by projecting its future cash flows, then discounting those amounts back to their present value. This approach helps investors see whether today's share price fairly reflects the company's long-term earning potential.

For Colgate-Palmolive, the current Free Cash Flow stands at $3.38 Billion. Analysts have supplied projections for the next few years, with future FCF expected to grow to $3.99 Billion by 2029. Beyond the analyst horizon, Simply Wall St extends these estimates using reasonable growth rates. As a result, projected cash flows are expected to continue rising over the coming decade.

After discounting all forecasted cash flows, the DCF model estimates Colgate-Palmolive's intrinsic value at $122.83 per share. This figure is about 36.0% above the current share price, indicating the stock may be meaningfully undervalued at this time.

This substantial discount suggests there could be an opportunity for long-term investors who believe in the company's future cash-generating ability.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Colgate-Palmolive is undervalued by 36.0%. Track this in your watchlist or portfolio, or discover 881 more undervalued stocks based on cash flows.

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Colgate-Palmolive.

The Price-to-Earnings (PE) ratio is a popular and useful metric for valuing profitable companies like Colgate-Palmolive. This multiple shows how much investors are willing to pay for each dollar of earnings, offering quick insight into how the market values a company's future potential relative to its current earnings.

Growth expectations and company-specific risks are key factors in determining what a reasonable or \\"fair\\" PE ratio should be. Companies with higher anticipated earnings growth or lower risk profiles can often command a premium, resulting in higher PE ratios. In contrast, slower-growing or riskier companies usually trade at lower multiples.

Colgate-Palmolive is currently trading at a PE ratio of 21.8x. For context, this stands above the Household Products industry average of 18.4x and its peers' average PE of 20.2x. At first glance, this might suggest the stock is slightly expensive compared to both the broader industry and direct competitors.

This is where the Simply Wall St “Fair Ratio” metric becomes valuable. The Fair Ratio for Colgate-Palmolive is calculated at 22.5x, factoring in the company’s growth outlook, profit margins, risks, size, and industry positioning. Unlike broad industry or peer comparisons, the Fair Ratio offers a more nuanced benchmark because it integrates all the material factors that drive a company's valuation.

Looking at Colgate-Palmolive’s current PE of 21.8x versus its Fair Ratio of 22.5x, the difference is less than 0.10x. This means the stock is trading in line with what is reasonable, suggesting it is priced about right based on earnings and underlying fundamentals.

Result: ABOUT RIGHT

PE ratios tell one story, but what if the real opportunity lies elsewhere? Discover 1408 companies where insiders are betting big on explosive growth.

Earlier we mentioned that there's an even better way to understand valuation, so let's introduce you to Narratives. A Narrative is simply your story of a company. It’s how you connect what you believe about Colgate-Palmolive’s future with the actual numbers behind its business, such as fair value, revenue estimates, earnings, and margins.

More than just a summary, a Narrative captures your perspective on where the business is heading and turns those expectations into financial forecasts and a fair value target. This approach links your understanding of a company’s real-world drivers, for example growth in emerging markets, margin expansion, or challenges like rising input costs, directly to investment decisions.

On Simply Wall St’s platform, anyone can easily create or follow Narratives on the Community page, making this dynamic tool accessible to millions of investors. Narratives empower you to decide not just what the “right price” is, but also when it makes sense to act. Each Narrative compares fair value to the actual share price, helping you determine if the stock is a buy, sell, or hold.

This information stays current as well. Whenever Colgate-Palmolive updates its earnings or news breaks, Narratives refresh with the latest data, ensuring your view is up to date. For example, some investors see Colgate-Palmolive’s fair value as high as $106 per share due to optimistic assumptions about innovation and emerging market growth, while others set it as low as $83 based on caution about competition and margin pressure. Narratives let you visualize these viewpoints at a glance so you can choose the story that makes the most sense for you.

Do you think there's more to the story for Colgate-Palmolive? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include CL.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com